Adatia I, Barrow S E, Stratton P D, Ritter J M, Haworth S G
Vascular Biology and Pharmacology Unit, Institute of Child Health, London.
Br Heart J. 1994 Nov;72(5):452-6. doi: 10.1136/hrt.72.5.452.
To investigate the effect of intracardiac repair on the abnormal biosynthesis of prostacyclin (PGI2) and thromboxane A2 (TXA2) in children with congenital heart disease and increased pulmonary blood flow.
A prospective study with immunoaffinity chromatography and gas chromatography-mass spectrometry to measure the urinary excretion products of PGI2 (2,3-dinor-6-oxo-prostaglandin (PG) F1 alpha (2,3-dinor-6-oxo-PGF1 alpha)) and TXA2 (2,3-dinor-TXB2) before operation, in the first 12-24 h after operation, and at discharge from hospital.
A supraregional referral centre for patients with congenital heart disease.
15 patients aged 2 to 60 months (median 7 months) with a left to right shunt who underwent intracardiac repair.
The preoperative 2,3-dinor-TXB2 excretion rate was greater than that found previously in a control group of 16 healthy children with a median (range) age of 24 (6-36) months (1159(201) v 592(122) ng/g creatinine in controls, P = 0.006). The excretion rate rose after operation to 9600(3832) ng/g creatinine (P = 0.01) and decreased before discharge to 1071(191) ng/g creatinine (NS), but remained greater than that of the control group (P = 0.014). Before operation 2,3-dinor-6-oxo-PGF1 alpha excretion rates were similar to those of the healthy children (482(68) v 589(95) ng/g creatinine in controls) but increased after operation to 19,668(11,162) ng/creatinine (P = 0.002) and fell at discharge to 1621(245) ng/g creatinine although this was higher than both preoperative and control rates (P = 0.005 and P = 0.0002 respectively). The preoperative ratio of 2,3-dinor-TXB2 to 2,3-dinor-6-oxo-PGF1 alpha excretion was greater than that of the control group (3.2(0.8) v 1.3(0.22) in controls, (P = 0.005)), decreased significantly after operation to 0.9(0.13) (P = 0.016), and changed little, to 0.7(0.12), before discharge. The last two ratios were similar to those in normal children and significantly lower than those before operation (P = 0.004).
In children with a left to right shunt the ratio of the excretion rates of the metabolites of TXA2 and PGI2 was abnormal before operation, which favoured vasoconstriction and platelet aggregation, but had decreased at discharge from hospital. The increase in excretion of PGI2 metabolites over TXA2 metabolite after intracardiac repair augurs well for pulmonary vascular recovery.
探讨心内修复术对先天性心脏病且肺血流量增加患儿前列环素(PGI2)和血栓素A2(TXA2)异常生物合成的影响。
一项前瞻性研究,采用免疫亲和色谱法和气相色谱 - 质谱法测量术前、术后12 - 24小时及出院时PGI2(2,3 - 二去甲 - 6 - 氧代 - 前列腺素(PG)F1α(2,3 - 二去甲 - 6 - 氧代 - PGF1α))和TXA2(2,3 - 二去甲 - TXB2)的尿排泄产物。
一家先天性心脏病患者的区域转诊中心。
15例年龄在2至60个月(中位数7个月)的左向右分流患儿接受了心内修复术。
术前2,3 - 二去甲 - TXB2排泄率高于先前一组年龄中位数(范围)为24(6 - 36)个月的16名健康儿童对照组(对照组肌酐为592(122)ng/g,研究组为1159(201)ng/g,P = 0.006)。术后排泄率升至9600(3832)ng/g肌酐(P = 0.01),出院前降至1071(191)ng/g肌酐(无统计学意义),但仍高于对照组(P = 0.014)。术前2,3 - 二去甲 - 6 - 氧代 - PGF1α排泄率与健康儿童相似(对照组肌酐为589(95)ng/g,研究组为482(68)ng/g),但术后增加至19,668(11,162)ng/肌酐(P = 0.002),出院时降至1621(245)ng/g肌酐,尽管高于术前和对照组水平(分别为P = 0.005和P = 0.0002)。术前2,3 - 二去甲 - TXB2与2,3 - 二去甲 - 6 - 氧代 - PGF1α排泄比值高于对照组(对照组为1.3(0.22),研究组为3.2(0.8),P = 0.005),术后显著降至0.9(0.13)(P = 0.016),出院前变化不大,为0.7(0.12)。最后两个比值与正常儿童相似,且显著低于术前水平(P = 0.004)。
左向右分流患儿术前TXA2和PGI2代谢产物排泄率比值异常,有利于血管收缩和血小板聚集,但出院时已降低。心内修复术后PGI2代谢产物排泄量相对于TXA2代谢产物增加,预示肺血管恢复良好。